Advanced Code injection

Arsheen Kaur 5/15/25 Arsheen Kaur 5/15/25

Ontario's Wet Lab Funding Shortage Could Drive Innovation Exodus

Read More

Arsheen Kaur 5/7/25 Arsheen Kaur 5/7/25

Zucara Therapeutics Announces Second and Final Closing of US$25 Million Series B Financing

Read More

Arsheen Kaur 5/7/25 Arsheen Kaur 5/7/25

Yellowbird Diagnostics Closes an Oversubscribed Funding Round

Read More

Arsheen Kaur 5/7/25 Arsheen Kaur 5/7/25

Lumira Ventures and Terry Fox Foundation Partner to Launch The Cancer Breakthrough Fund

Read More

Arsheen Kaur 5/7/25 Arsheen Kaur 5/7/25

Conavi Medical Closes $20M Public Offering

Read More

Doriane Rey 5/6/25 Doriane Rey 5/6/25

MEDTEQ+ and OBIO® Join Forces to Accelerate the Development of AgeTech Innovations Across Canada

Read More

Arsheen Kaur 4/23/25 Arsheen Kaur 4/23/25

Canada Should Invest in Itself Instead of Subsidizing Foreign Biotechnology Companies

Read More

Arsheen Kaur 4/22/25 Arsheen Kaur 4/22/25

AmacaThera Partners with Global Pharma to Develop Long-Acting Biologic Using AmacaGel™

Read More

Arsheen Kaur 4/9/25 Arsheen Kaur 4/9/25

Spiderwort Biotechnologies Announces State-of-the-Art ISO 5 Cleanroom Facility

Read More

Arsheen Kaur 4/9/25 Arsheen Kaur 4/9/25

The Ottawa Hospital & Gray Oncology Expand their Partnership to Support Transplant & Cell Therapies

Read More

Arsheen Kaur 3/11/25 Arsheen Kaur 3/11/25

Stem Cell Network and Capital BioVentures Announce a Strategic Partnership to Drive Canadian Regenerative Innovations Forward

Read More

Arsheen Kaur 3/11/25 Arsheen Kaur 3/11/25

Afynia Laboratories Closes $5M Seed Round, Proceeds to Help Revolutionize Endometriosis Care

Read More

Arsheen Kaur 3/11/25 Arsheen Kaur 3/11/25

OBIO® and TIAP Invest in A4i to Advance AI Analytics for Mental Health Risk Detection

Read More

Arsheen Kaur 3/6/25 Arsheen Kaur 3/6/25

FACIT and OBIO® announce inaugural WeSEED cohort of women-led start-ups in joint seed capital and commercialization program

Read More

Arsheen Kaur 2/26/25 Arsheen Kaur 2/26/25

OBIO® Selected by Scale AI to Provide Additional Support to Start-ups

Read More

Arsheen Kaur 2/26/25 Arsheen Kaur 2/26/25

Paradox Immunotherapeutics Secures $10M Investment to Advance Therapies for Protein Misfolding Diseases

Read More

Arsheen Kaur 2/24/25 Arsheen Kaur 2/24/25

Treatment AI Acquires Rocket Doctor to Enhance Digital Health

Read More

Doriane Rey 2/19/25 Doriane Rey 2/19/25

OBIO® secures funding from Government of Canada to expand Canada's manufacturing capabilities and bring innovations to market

Read More

Arsheen Kaur 2/12/25 Arsheen Kaur 2/12/25

Showcasing the strength of the Canadian life sciences industry at the OBIO® Investment Summit

Read More

Arsheen Kaur 2/12/25 Arsheen Kaur 2/12/25

AstraZeneca to Invest $820M in Ontario's Life Sciences Sector

Read More